The correlation between PDL1 upregulation and elevated tumor cell proliferation (Ki67) and more proliferative molecular subtypes might be explained by the higher mutation rate of hyperproliferative tumor cells, potentially responsible for higher immunogenicity due to the rapid appearance of neoantigens. Here, MKI67 is linked to neoplasm.